News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
41,487 Results
Type
Article (3124)
Company Profile (89)
Press Release (38274)
Section
Business (13945)
Career Advice (62)
Deals (2183)
Drug Delivery (3)
Drug Development (6698)
Employer Resources (14)
FDA (619)
Job Trends (1470)
News (22480)
Policy (1211)
Tag
Academia (136)
Allergies (4)
Alliances (3570)
ALS (11)
Alzheimer's disease (150)
Antibody-drug conjugate (ADC) (8)
Approvals (632)
Artificial intelligence (24)
Autoimmune disease (5)
Automation (1)
Bankruptcy (18)
Best Places to Work (1143)
Biotechnology (70)
Bladder cancer (1)
Brain cancer (3)
Breast cancer (30)
Cancer (155)
Cardiovascular disease (9)
Career advice (59)
Career pathing (3)
CAR-T (12)
Cell therapy (37)
Cervical cancer (1)
Clinical research (5212)
Collaboration (95)
Company closure (1)
Compensation (79)
COVID-19 (129)
CRISPR (7)
C-suite (40)
Cystic fibrosis (9)
Data (200)
Depression (2)
Diabetes (6)
Diagnostics (206)
Digital health (1)
Diversity, equity & inclusion (2)
Drug discovery (13)
Duchenne muscular dystrophy (14)
Earnings (4364)
Editorial (2)
Employer branding (3)
Employer resources (12)
Events (8510)
Executive appointments (86)
FDA (709)
Frontotemporal dementia (2)
Funding (54)
Gene editing (19)
Generative AI (2)
Gene therapy (20)
GLP-1 (29)
Government (120)
Guidances (8)
Healthcare (1182)
Huntington's disease (6)
IgA nephropathy (3)
Immunology and inflammation (7)
Indications (2)
Infectious disease (138)
Inflammatory bowel disease (10)
Influenza (5)
Intellectual property (10)
Interviews (6)
IPO (1305)
Job creations (414)
Job search strategy (57)
Labor market (9)
Layoffs (71)
Legal (182)
Liver cancer (3)
Lung cancer (28)
Lymphoma (2)
Machine learning (2)
Management (2)
Manufacturing (12)
MASH (2)
Medical device (184)
Medtech (184)
Mergers & acquisitions (909)
Metabolic disorders (23)
Multiple sclerosis (4)
Neurodegenerative disease (9)
Neuroscience (203)
NextGen: Class of 2025 (390)
Non-profit (90)
Now hiring (12)
Obesity (16)
Opinion (9)
Ovarian cancer (3)
Pain (3)
Pancreatic cancer (11)
Parkinson's disease (12)
Patents (15)
Patient recruitment (5)
People (5088)
Pharmaceutical (15)
Phase I (1996)
Phase II (2353)
Phase III (1508)
Pipeline (117)
Postmarket research (94)
Preclinical (1025)
Prostate cancer (1)
Radiopharmaceuticals (18)
Rare diseases (36)
Real estate (634)
Recruiting (8)
Regulatory (1012)
Reports (1)
Research institute (134)
Resumes & cover letters (4)
RNA editing (1)
RSV (5)
Schizophrenia (11)
Series A (14)
Series B (3)
Service/supplier (1)
Sickle cell disease (10)
Spinal muscular atrophy (18)
Sponsored (1)
Startups (479)
Tariffs (1)
Vaccines (33)
Venture capital (4)
Weight loss (2)
Worklife (1)
Date
Today (6)
Last 7 days (23)
Last 30 days (109)
Last 365 days (1945)
2025 (1088)
2024 (2290)
2023 (2822)
2022 (3542)
2021 (4129)
2020 (3531)
2019 (2795)
2018 (2104)
2017 (2389)
2016 (2319)
2015 (2339)
2014 (1434)
2013 (1164)
2012 (1361)
2011 (1300)
2010 (1290)
Location
Africa (28)
Alaska (1)
Arizona (1)
Asia (1636)
Australia (174)
California (108)
Canada (71)
China (38)
Colorado (5)
Connecticut (4)
Delaware (27)
Europe (8367)
Florida (55)
Georgia (3)
Hawaii (1)
Illinois (9)
India (1)
Indiana (4)
Iowa (1)
Japan (44)
Maryland (15)
Massachusetts (1778)
Michigan (2)
Minnesota (2)
Nebraska (1)
New Hampshire (1)
New Jersey (24)
New Mexico (1)
New York (27)
North Carolina (27)
North Dakota (1)
Northern California (59)
Ohio (6)
Oregon (3)
Pennsylvania (12)
Rhode Island (3)
South America (36)
South Carolina (1)
Southern California (29)
Texas (42)
United States (2150)
Utah (3)
Virginia (3)
Washington D.C. (1)
Washington State (116)
Wisconsin (3)
41,487 Results for "cambridge epigenetix".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Defence Therapeutics Opens U.S. Laboratory in Boston-Cambridge Biotech Hub
June 2, 2025
·
3 min read
Press Releases
Cambridge Isotope Laboratories Launches ISOLED-D: Revolutionary Deuterated Reagents for OLED Manufacturing
May 20, 2025
·
1 min read
Press Releases
LIfT BioSciences joins Bayer Co.Lab Cambridge, securing access to cutting-edge lab facilities
June 4, 2025
·
2 min read
Press Releases
Nikon Instruments and Astellas announce a strategic collaboration to offer SakuLab-Cambridge MA resident companies access to advanced imaging capabilities provided by Nikon BioImaging Lab USA
June 17, 2025
·
2 min read
Business
Moderna Moves Cambridge Employees Into New Headquarters
The new Cambridge, Mass.–based facility is about 460,000 square feet. Labs occupy nearly 50% of the space.
April 2, 2024
·
4 min read
·
Angela Gabriel
Genetown
Cambridge Biotherapies Expands Innovative Services with Ketamine Infusions for Opioid-Free Pain Management
Cambridge Biotherapies proudly announces the launch of Ketamine Infusions for Pain and Headache Management, now available at all locations.
May 22, 2024
·
3 min read
Genetown
Cambridge Isotope Laboratories (CIL) Shows Long-Term Commitment to Xenia, Ohio, Facility With New Land Purchase
Cambridge Isotope Laboratories, Inc. has acquired an additional 14.8 acres of land at its Cambridge Isotope Separations Xenia, Ohio location.
April 25, 2024
·
2 min read
Genetown
Cambridge-Based Biotech SynDevRx Announces Scientific Publication Describing Optimized Drug Conjugate Targeting Tumors Sensitive to Obesity/Metabolic Hormones
SynDevRx, Inc., a pioneering clinical-stage biotechnology company based in Cambridge, Massachusetts, has achieved a significant milestone.
March 28, 2024
·
5 min read
BioMidwest
Next Gen Diagnostics Announces Opening of a US Sequencing and Bioinformatics Laboratory in Cambridge, Massachusetts
Next Gen Diagnostics announces its first US laboratory will be opening in Cambridge, Massachusetts, to provide low-cost, fully integrated bacterial sequencing and bioinformatics to US customers and partners.
June 11, 2024
·
3 min read
BIOMODAL LAUNCHES SOLUTION TO SIMULTANEOUSLY SEQUENCE GENETICS AND EPIGENETICS IN ONE WORKFLOW
biomodal (formerly known as Cambridge Epigenetix) commercially launches its new duet multiomics solution, revealing the combinatorial power of genetic and epigenetic information from a single low volume sample.
April 13, 2023
·
6 min read
1 of 4,149
Next
